# Allopurinol Effect on MDA,NO,KIM-1 Urine Levels, RI and Renal Elastography in Kidney Stone Patients Post ESWL

> **NCT05414669** · PHASE4 · COMPLETED · sponsor: **Sanglah General Hospital** · enrollment: 35 (actual)

## Conditions studied

- Kidney Calculi

## Interventions

- **DRUG:** Allopurinol Tablet 300 mg
- **DRUG:** Control Group

## Key facts

- **NCT ID:** NCT05414669
- **Lead sponsor:** Sanglah General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-06
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-04-20
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414669, "Allopurinol Effect on MDA,NO,KIM-1 Urine Levels, RI and Renal Elastography in Kidney Stone Patients Post ESWL". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05414669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*